相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials
Rafael G. dos Santos et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2022)
Determination of up to twenty carboxylic acid containing compounds in clinically relevant matrices by o-benzylhydroxylamine derivatization and liquid chromatography-tandem mass spectrometry.
Alex Gomez-Gomez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies
Kristoffer A. A. Andersen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being
Maggie K. Kiraga et al.
FRONTIERS IN PHARMACOLOGY (2021)
Applications of Metabolomics in Forensic Toxicology and Forensic Medicine
Michal Szeremeta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients
Judith Marin-Corral et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos et al.
FRONTIERS IN PSYCHIATRY (2021)
Ayahuasca potential benefits
R. Pinilla et al.
EUROPEAN PSYCHIATRY (2021)
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease
Albert Katchborian-Neto et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
Rainer Spanagel
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
METABOLOMICS FOR INVESTIGATING PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL PROCESSES
David S. Wishart
PHYSIOLOGICAL REVIEWS (2019)
DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays
Amrit Singh et al.
BIOINFORMATICS (2019)
Metabolomics predicts the pharmacological profile of new psychoactive substances
Eulalia Olesti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Quantification of endogenous neurotransmitters and related compounds by liquid chromatography coupled to tandem mass spectrometry
Eulalia Olesti et al.
TALANTA (2019)
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2019)
The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
Maurizio S. Riga et al.
NEUROPHARMACOLOGY (2018)
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
NEUROPSYCHOPHARMACOLOGY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
FELLA: an R package to enrich metabolomics data
Sergio Picart-Armada et al.
BMC BIOINFORMATICS (2018)
Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and Endocannabinoids in a Healthy Human Subject
Rafael Guimaraes dos Santos et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Null diffusion-based enrichment for metabolomics data
Sergio Picart-Armada et al.
PLOS ONE (2017)
Hierarchical cluster analysis in clinical research with heterogeneous study population: highlighting its visualization with R
Zhongheng Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CBI receptors
Helen de Morais et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
Marta Valle et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry
Josep Marcos et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Ayahuasca Treatment Center Safety for the Western Seeker
Raven Renee Ray et al.
ANTHROPOLOGY OF CONSCIOUSNESS (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Serum metabolomics in rats models of ketamine abuse by gas chromatography-mass spectrometry
Meiling Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Vinals et al.
PLOS BIOLOGY (2015)
Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs
Antoni Pastor et al.
JOURNAL OF LIPID RESEARCH (2014)
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
David Baumeister et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels
Giorgio Ortar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse
Tian Zheng et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Analytical techniques for the determination of tryptamines and ß-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices
Alain Gaujac et al.
DRUG TESTING AND ANALYSIS (2012)
Visualising associations between paired 'omics' data sets
Ignacio Gonzalez et al.
BIODATA MINING (2012)
Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges
Beatriz Caiuby Labate et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2012)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy Expenditure
Reiner Jumpertz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
integrOmics: an R package to unravel relationships between two omics datasets
Kim-Anh Le Cao et al.
BIOINFORMATICS (2009)
Repeated double cross validation
Peter Filzmoser et al.
JOURNAL OF CHEMOMETRICS (2009)
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
Matthew N. Hill et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
Robert S. Gable
ADDICTION (2007)
Serotonin 5-HT2A receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism
Jason C. Parrish et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics
J Schafer et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2005)
Tryptophan hydroxylase-2 controls brain serotonin synthesis
XD Zhang et al.
SCIENCE (2004)
Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR
CJ Lynch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
分享论文
